Wells Fargo and Stifel Flag Beneficiaries of Moderna-Merck Cancer Vaccine Data

Wells Fargo and Stifel say Moderna and Merck's Phase 3 cancer vaccine data could benefit Repligen, Danaher, Thermo Fisher, and Maravai LifeSciences. TEM stock is also surging.